LYZ and infection: Our review highlights current therapeutic options available for potential clinical use, such as antimicrobial photodynamic therapy (aPDT), liposomal photocatalytic carriers, and nanoparticles, either as standalone treatments or as part of combination therapies with agents such as antibiotics, lysozyme, and bacteriophage-derived enzymes, aiming not only to control infection progression but also to eradicate it, prevent recurrence, and, most importantly, facilitate effective tissue regeneration.